Barchart Research What to Expect from MASI Earnings MASI Generated June 1, 2026 Current Price $178.59 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Legal Victory Tour Meets the...
Barchart Research What to Expect from MASI Earnings MASI Generated May 25, 2026 Current Price $178.81 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Final Independent Quarter Before...
Barchart Research What to Expect from MASI Earnings MASI Generated May 22, 2026 Current Price $178.81 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Danaher Merger Caps a Turnaround...
Barchart Research What to Expect from MASI Earnings MASI Generated May 22, 2026 Current Price $178.81 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Danaher Merger Caps a Turnaround...
Barchart Research What to Expect from MASI Earnings MASI Generated May 22, 2026 Current Price $178.81 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Danaher Merger Caps a Turnaround...
Barchart Research What to Expect from MASI Earnings MASI Generated May 18, 2026 Current Price $178.80 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's First Earnings Under Danaher...
Barchart Research What to Expect from MASI Earnings MASI Generated May 11, 2026 Current Price $178.50 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Tariff Mitigation Strategy Faces...
Barchart Research What to Expect from MASI Earnings MASI Generated May 4, 2026 Current Price $178.21 EPS Estimate $$1.41 Consensus Rating Hold Average Move 9.91% Masimo's Pre-Announced Earnings: The Rare...
Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced...
NICU Study Adds to the Evidence Demonstrating SET ® ’s Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance Across Skin Pigmentation...